High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity

Microvascular Research

Volumn 82, Issue 3, 2011, Pages 356-363

  Tsai, Shu Huai ^a,b   Hein, Travis W ^b   Kuo, Lih ^b   Yang, Vivian C ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CYTOCHROME P450; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; GLUCOSE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE; SUPEROXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL PIG; FATTY ACID SYNTHESIS; HYPERGLYCEMIA; LONG TERM EXPOSURE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VASOMOTOR REFLEX;

ANIMALS; ARTERIOLES; BIOLOGICAL FACTORS; CELLS, CULTURED; CORONARY VESSELS; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EICOSANOIDS; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GLUCOSE; HYPERGLYCEMIA; NITRIC OXIDE; SUPEROXIDES; SWINE; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

SUS;

EID: 81055140213     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.09.008     Document Type: Article

References (58)

1. Ammar R.F., Gutterman D.D., Brooks L.A., Dellsperger K.C. Free redicals mediate endothelial dysfunction of coronary arterioles in diabetes. Cardiovasc. Res. 2000, 47:595-601.
2. Angulo J., Cuevas P., Fernández A., Gabancho S., Allona A., Martín-Morales A., Moncada I., Videla S., Sáenz de Tejada I. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem. Biophys. Res. Commun. 2003, 312:1202-1208.
3. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996, 94:3341-3347.
4. Bauersachs J., Christ M., Ertl G., Michaelis U.R., Fisslthaler B., Busse R., Fleming I. Cytochrome P450 2C expression and EDHF-mediated relaxation in porcine coronary arteries is increased by cortisol. Cardiovasc. Res. 2002, 54:85-94.
5. Bertrand M.E. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr. Med. Res. Opin. 2004, 20:1559-1569.
6. Bryan R.M., You J., Golding E.M., Marrelli S.P. Endothelium-derived hyperpolarizing factor. A cousin to nitric oxide and prostacyclin. Anesthesiology 2005, 102:1261-1277.
7. Camici P.G., Crea F. Coronary microvascular dysfunction. N. Engl. J. Med. 2007, 356:830-840.
8. Chilian W.M., Eastham C.L., Marcus M.L. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am. J. Physiol. 1986, 251:779-788.
9. Creager M.A., Lüscher T.F., Cosentino F., Beckman J.A. Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003, 108:1527-1532.
10. Ding H., Aljofan M., Triggle C.R. Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells. J. Cell. Physiol. 2007, 212:682-689.
11. Du X., Edelstein D., Obici S., Higham N., Zou M., Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J. Clin. Invest. 2006, 116:1071-1080.
12. Enseleit F., Hürlimann D., Lüscher T.F. Vascular protective effects of angiotensin converting enzyme inhibitors and their regulation to clinical events. J. Cardiovasc. Pharmacol. 2001, 37(Suppl. 1):S21-S30.
13. Félétou M., Vanhoutte P.M. Endothelial dysfunction: a multifaceted disorder. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H985-H1002.
14. Ferrari R., Fox K. Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story. Drugs 2009, 69:265-277.
15. Fisslthaler B., Popp R., Kiss L., Potente M., Harder D.R., Fleming I., Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999, 401:493-497.
16. Gao L., Mann G.E. Vascular NAD(P)H oxidase activation in diabetes: adouble-edged sword in redox signaling. Cardiovasc. Res. 2009, 82:9-20.
17. db mice. Circulation 2007, 115:245-254.
18. Gao X., Zhang H., Schmidt A.M., Zhang C. AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H491-H498.
19. Groves P., Kurz S., Just H., Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation 1995, 92:3424-3430.
20. Gupte S., Labinskyy N., Gupte R., Csiszar A., Ungvari Z., Edwards J.G. Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM. PLoS One 2010, 5:e11800.
21. Hadi H.A., Suwaidi J.A. Endothelial dysfunction in diabetes mellitus. Vasc. Health Risk Manag. 2007, 3:853-876.
22. ATP channels. Circ. Res. 1999, 85:634-642.
23. Hein T.W., Qamirani E., Ren Y., Kuo L. C-reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: role of peroxynitrite. J. Mol. Cell. Cardiol. 2009, 47:196-202.
24. Hoshiyama M., Li B., Yao J., Harada T., Morioka T., Oite T. Effect of high glucose on nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp. Nephrol. 2003, 95:e62-e68.
25. Ishizaka H., Kuo L. Endothelial ATP-sensitive potassium channels mediate coronary microvascular dilation to hyperosmolarity. Am. J. Physiol. 1997, 173:H104-H112.
26. Kinlay S., Libby P., Ganz P. Endothelial function and coronary artery disease. Curr. Opin. Lipidol. 2001, 12:383-389.
27. Kuo L., Davis M.J., Chilian W.M. Myogenic activity in isolated subepicardial and subendocardial coronary arterioles. Am. J. Physiol. 1988, 255:H1558-H1562.
28. Kuo L., Davis M.J., Chilian W.M. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am. J. Physiol. 1990, 259:H1063-H1070.
29. Kuo L., Chilian W.M., Davis M.J. Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am. J. Physiol. 1991, 261:H1706-H1715.
30. Larsen B.T., Gutterman D.D., Sato A., Toyama K., Campbell W.B., Zeldin D.C., Manthati V.L., Falck J.R., Miura H. Hydrogen peroxide inhibits cytochrome P450 epoxygenase: interaction between two endothelium-derived hyperpolarizing factors. Circ. Res. 2008, 102:59-67.
31. Linz W., Wiemer G., Schölkens B.A. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J. Mol. Cell. Cardiol. 1992, 24:909-919.
32. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., Ferguson T.B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P.M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M.M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V.L., Rosamond W., Sacco R., Sorlie P., Stafford R., Thom T., Wasserthiel-Smoller S., Wong N.D., Wylie-Rosett J. AHA heart disease and stroke statistics 2010 update: A report from the American Heart Association. Circulation 2010, 121:e46-e215. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
33. Luksha L., Agewall S., Kublickiene K. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis 2009, 202:330-344.
34. Marcus M.L., Chilian W.M., Kanatsuka H., Dellsperger K.C., Eastham C.L., Lamping K.G. Understanding the coronary circulation through studies at the microvascular level. Circulation 1990, 82:1-7.
35. Matsumoto T., Kobayashi T., Kamata K. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Eur. J. Pharmacol. 2006, 538:132-140.
36. Matsumoto T., Kakami M., Noguchi E., Kobayashi T., Kamata K. Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1480-H1490.
37. + channels. Circ. Res. 1998, 83:501-507.
38. Miura H., Liu Y., Gutterman D.D. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. Circulation 1999, 99:3132-3138.
39. Nagaoka T., Hein T.W., Yoshida A., Kuo L. Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Invest. Ophthalmol. Vis. Sci. 2007, 48:4232-4239.
40. Nakashima M., Mombouli J.V., Taylor A.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J. Clin. Invest. 1993, 92:2867-2871.
41. Nie H., Wu J., Zhang M., Xu J., Zou M. Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo. Diabetes 2006, 55:3133-3141.
42. Nishikawa Y., Stepp D.W., Chilian W.M. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am. J. Physiol. 1999, 277:H1252-H1259.
43. Nishikawa Y., Stepp D.W., Chilian W.M. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H459-H465.
44. Nishikawa T., Kukidome D., Sonoda K., Fujisawa K., Matsuhisa T., Motoshima H., Matsumura T., Araki E. Impact of mitochondrial ROS production on diabetic vascular complications. Diabetes Res. Clin. Pract. 2007, 77S:S41-S45.
45. Pannirselvam M., Ding H., Anderson T.J., Triggle C.R. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur. J. Pharmacol. 2006, 551:98-107.
46. Park Y., Capobianco S., Gao X., Falck J.R., Dellsperger K.C., Zhang C. Role of EDHF in type 2 diabetes-induced endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1982-H1988.
47. Perez M., Molinaro G., Adam A. Bradykinin, an important mediator of cardiovascular effects of metallopeptidase inhibitors: experimental and clinical evidences. J. Clin. Basic Cardiol. 2001, 4:39-46.
48. Pricci F., Leto G., Amadio L., Iacobini C., Cordone S., Catalano S., Zicari A., Sorcini M., Di Mario U., Pugliese G. Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radic. Biol. Med. 2003, 35:683-694.
49. Qamirani E., Ren Y., Kuo L., Hein T.W. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 2005, 25:995-1001.
50. Romero M., Platt D.H., Tawfik H.E., Labazi M., El-Remessy A.B., Bartoli M., Caldwell R.B., Caldwell R.W. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ. Res. 2008, 102:95-102.
51. Schlkens B.A., Linz W., Martorana P.A. Experimental cardiovascular benefits of angiotensin converting enzyme inhibitors: beyond blood pressure reduction. J. Cardiovasc. Pharmacol. 1991, 18(Suppl. 2):S26-S30.
52. Tawfik H.E., El-Remessy A.B., Matragoon S., Ma G., Caldwell R.B., Caldwell R.W. Simvastatin improves diabetes-induced coronary endothelial dysfunction. J. Pharmacol. Exp. Ther. 2006, 319:386-395.
53. 2 mediation. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3096-H3104.
54. Tsai S.H., Liu Y.W., Tang W.C., Zhou Z.W., Hwang C.Y., Hwang G.Y., Ou B.R., Hu C.P., Yang V.C., Chen J.K. Characterization of porcine arterial endothelial cells cultured on amniotic membrane, a potential matrix for vascular tissue engineering. Biochem. Biophys. Res. Commun. 2007, 357:984-990.
55. Waldron G.J., Ding H., Lovren F., Kubes P., Triggle C.R. Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br. J. Pharmacol. 1999, 128:653-658.
56. 2+ ATPase in diabetic pig aorta. Free Radic. Biol. Med. 2008, 45:756-762.
57. Zhang C., Hein T.W., Wang W., Kuo L. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ. Res. 2003, 92:322-329.
58. Zhou W., Wang X.L., Lamping K.G., Lee H.C. Inhibition of protein kinase Cβ protects against diabetes-induced impairment in arachidonic acid dilation of small coronary arteries. J. Pharmacol. Exp. Ther. 2006, 319:199-207.